Video

Neoadjuvant Therapy in Early-Stage NSCLC: CheckMate-816 Study

Overview and clinical implications of the CheckMate-816 study of neoadjuvant nivolumab plus platinum chemotherapy versus chemotherapy alone in early-stage NSCLC.

Video Player is loading.
Current Time 0:00
Duration 3:20
Loaded: 0%
Stream Type LIVE
Remaining Time 3:20
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected